Clinical Trial Update: Effects of Propofol and Isoflurane on Pulmonary Vascular Resistance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effects of propofol and isoflurane on pulmonary vascular resistance in pulmonary hypertension, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• PROPOFOL (Propofol)
• isoflurane (isoflurane)

Snippet

Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust | Conditions: Hypertension, Pulmonary | Phase 4 | Status: COMPLETED